Skip to main content

MoonLake Immunotherapeutics insider trading

MLTXNASDAQ
$11.41-0.06 (-0.52%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+52.9%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

    AI Activity Analysis

    Premium
    Coming soonAI reads of insider activity will appear here for Premium accounts.

    Insider activity

    Fromto
    CompanyInsider / roleActionΔOwnAvg priceAmount
    MLTXKristian ReichChief Scientific OfficerOpen market sell$22K0.0%$20.00$22KJul 27, 2026Jul 29, 2026
    MLTXKristian ReichChief Scientific OfficerOpen market sell$49K-0.1%$20.00$49KJul 22, 2026Jul 23, 2026
    MLTXKristian ReichChief Scientific OfficerOpen market sell$1M-1.8%$20.02$1MJul 21, 2026Jul 23, 2026
    MLTXKristian ReichChief Scientific OfficerOpen market sell$878K-1.5%$20.09$878KJul 20, 2026Jul 21, 2026
    MLTXKristian ReichChief Scientific OfficerOpen market sell$322K-0.6%$20.01$322KJul 15, 2026Jul 20, 2026
    MLTXDa Silva Jorge SantosChief Executive OfficerOpen market sell$1.37M-2.4%$20.02$1.37MJul 10, 2026Jul 13, 2026
    MLTXDa Silva Jorge SantosChief Executive OfficerOpen market sell$679K-1.2%$20.01$679KJul 9, 2026Jul 13, 2026
    MLTXDa Silva Jorge SantosChief Executive OfficerOpen market sell$957K-1.6%$20.03$957KJul 1, 2026Jul 2, 2026
    MLTXMatthias BodenstedtChief Financial OfficerOpen market sell$862K-3.4%$22.04$862KJun 22, 2026Jun 23, 2026
    MLTXMatthias BodenstedtChief Financial OfficerOpen market sell$54.8K-0.2%$19.60$54.8KJun 18, 2026Jun 18, 2026
    MLTXMatthias BodenstedtChief Financial OfficerOpen market sell$297K-1.3%$19.68$297KJun 17, 2026Jun 18, 2026
    MLTXKristian ReichChief Scientific OfficerOpen market sell$972K-1.7%$19.43$972KJun 17, 2026Jun 17, 2026
    MLTXKristian ReichChief Scientific OfficerOpen market sell$935K-1.7%$18.70$935KJun 16, 2026Jun 17, 2026
    MLTXKristian ReichChief Scientific OfficerOpen market sell$945K-1.7%$18.89$945KJun 15, 2026Jun 17, 2026
    MLTXMatthias BodenstedtChief Financial OfficerOpen market sell$273K-1.2%$20.02$273KMay 11, 2026May 13, 2026
    MLTXMatthias BodenstedtChief Financial OfficerOpen market sell$47.5K-0.2%$19.56$47.5KApr 14, 2026Apr 16, 2026
    MLTXDa Silva Jorge SantosChief Executive OfficerOpen market sell$946K-1.7%$18.23$946KApr 13, 2026Apr 14, 2026
    MLTXDa Silva Jorge SantosChief Executive OfficerOpen market sell$1.81M-3.2%$18.41$1.81MApr 10, 2026Apr 14, 2026
    MLTXMatthias BodenstedtChief Financial OfficerOpen market sell$37.6K-0.2%$19.51$37.6KApr 10, 2026Apr 10, 2026
    MLTXMatthias BodenstedtChief Financial OfficerOpen market sell$1.63M-6.7%$18.94$1.63MApr 9, 2026Apr 10, 2026
    MLTXMark N. LampertDirectorOpen market sell$4.17M-19.3%$16.79$4.17MMar 31, 2026Apr 2, 2026
    MLTXMark N. LampertDirectorOpen market sell$26.3M-19.2%$16.79$26.3MMar 31, 2026Apr 2, 2026
    MLTXMark N. LampertDirectorOpen market sell$32.4M-18.9%$16.79$32.4MMar 31, 2026Apr 2, 2026
    MLTXDa Silva Jorge SantosChief Executive OfficerOpen market sell$1.01M-2.4%$14.49$1.01MDec 9, 2025Dec 10, 2025
    MLTXKristian ReichChief Scientific OfficerOpen market sell$1.05M-2.4%$14.43$1.05MDec 9, 2025Dec 10, 2025
    MLTXDa Silva Jorge SantosChief Executive OfficerOpen market sell$1.96M-4.2%$15.08$1.96MDec 8, 2025Dec 10, 2025
    MLTXKristian ReichChief Scientific OfficerOpen market sell$1.96M-4.1%$15.08$1.96MDec 8, 2025Dec 10, 2025
    MLTXMatthias BodenstedtChief Financial OfficerOpen market purchase$98.8K+1.8%$9.09$98.8KOct 8, 2025Oct 9, 2025
    End of history · 28 transactions

    Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.